Literature DB >> 12706439

Doxycycline in the treatment of human onchocerciasis: Kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms.

Achim Hoerauf1, Sabine Mand, Lars Volkmann, Marcelle Büttner, Yeboah Marfo-Debrekyei, Mark Taylor, Ohene Adjei, Dietrich W Büttner.   

Abstract

Recently, experts have warned that mass treatment with ivermectin alone may not interrupt the transmission of Onchocerca. Hence, additional drugs are needed, such as antibiotics acting on symbiotic endobacteria of the filariae, the causative agents of onchocerciasis. Based on animal experiments, human onchocerciasis was treated with doxycycline, and preliminary observations published in 2001 in The Lancet showed sterility in female worms by depletion and marked reduction in symbiotic Wolbachia endobacteria from the filariae. Here, a detailed kinetic analysis of the features of the worms, following administration or not of doxycycline to the patients is reported. Sixty-three onchocerciasis patients in Ghana were treated with 100 mg doxycycline daily for 6 weeks and 2 or 6 months later with ivermectin. Onchocercomas were extirpated 2, 6, 11 and 18 months after the onset of treatment and the filariae were examined by immunohistology and PCR. The analysis showed: (i) progressive depletion of Wolbachia from adult worms and microfilariae by doxycycline over a period of 6 months; (ii) inhibition of embryogenesis by doxycycline after 6 months with respect to all embryo stages followed by decline in microfilariae after 11 months; (iii) reduction in spermatozoa in the female genital tract by doxycycline, whereas spermiogenesis was only partly reduced after 11 and 18 months; (iv) no relevant macro- or microfilaricidal activity; (v) depletion/marked reduction in endobacteria and inhibition of embryogenesis were sustained until 18 months after doxycycline and 12 months after co-administration of ivermectin; (vi) no severe adverse side effects were seen. Due to its long-lasting inhibition of embryogenesis, doxycycline presents an additional strategy for the treatment of onchocerciasis and control of Onchocerca microfilariae transmission. Extension of the existing registration will not require much time or high cost. Treatment of individual patients can be considered immediately.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706439     DOI: 10.1016/s1286-4579(03)00026-1

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  68 in total

1.  Wolbachia in filarial parasites: targets for filarial infection and disease control.

Authors:  Kelly L Johnston; Mark J Taylor
Journal:  Curr Infect Dis Rep       Date:  2007-01       Impact factor: 3.725

2.  Protective immunity to the larval stages of onchocerca volvulus is dependent on Toll-like receptor 4.

Authors:  Laura A Kerepesi; Ofra Leon; Sarah Lustigman; David Abraham
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

3.  Homology modeling of NAD+-dependent DNA ligase of the Wolbachia endosymbiont of Brugia malayi and its drug target potential using dispiro-cycloalkanones.

Authors:  Nidhi Shrivastava; Jeetendra K Nag; Jyoti Pandey; Rama Pati Tripathi; Priyanka Shah; Mohammad Imran Siddiqi; Shailja Misra-Bhattacharya
Journal:  Antimicrob Agents Chemother       Date:  2015-04-06       Impact factor: 5.191

4.  The Wolbachia Symbiont: Here, There and Everywhere.

Authors:  Emilie Lefoulon; Jeremy M Foster; Alex Truchon; C K S Carlow; Barton E Slatko
Journal:  Results Probl Cell Differ       Date:  2020

Review 5.  Onchocerciasis: the role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treatment.

Authors:  Francesca Tamarozzi; Alice Halliday; Katrin Gentil; Achim Hoerauf; Eric Pearlman; Mark J Taylor
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

6.  Efficacy of 5-week doxycycline treatment on adult Onchocerca volvulus.

Authors:  Achim Hoerauf; Sabine Specht; Yeboah Marfo-Debrekyei; Marcelle Büttner; Alexander Yaw Debrah; Sabine Mand; Linda Batsa; Norbert Brattig; Peter Konadu; Claudio Bandi; Rolf Fimmers; Ohene Adjei; Dietrich W Büttner
Journal:  Parasitol Res       Date:  2008-10-11       Impact factor: 2.289

7.  Efficacy of 2- and 4-week rifampicin treatment on the Wolbachia of Onchocerca volvulus.

Authors:  Sabine Specht; Sabine Mand; Yeboah Marfo-Debrekyei; Alexander Yaw Debrah; Peter Konadu; Ohene Adjei; Dietrich W Büttner; Achim Hoerauf
Journal:  Parasitol Res       Date:  2008-08-05       Impact factor: 2.289

8.  Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study.

Authors:  Achim Hoerauf; Sabine Specht; Marcelle Büttner; Kenneth Pfarr; Sabine Mand; Rolf Fimmers; Yeboah Marfo-Debrekyei; Peter Konadu; Alexander Yaw Debrah; Claudio Bandi; Norbert Brattig; Anna Albers; John Larbi; Linda Batsa; Mark J Taylor; Ohene Adjei; Dietrich W Büttner
Journal:  Med Microbiol Immunol       Date:  2007-11-13       Impact factor: 3.402

9.  Newly acquired Onchocerca volvulus filariae after doxycycline treatment.

Authors:  Sabine Specht; Achim Hoerauf; Ohene Adjei; Alexander Debrah; Dietrich W Büttner
Journal:  Parasitol Res       Date:  2009-09-16       Impact factor: 2.289

10.  Criteria for the differentiation between young and old Onchocerca volvulus filariae.

Authors:  Sabine Specht; Norbert Brattig; Marcelle Büttner; Dietrich W Büttner
Journal:  Parasitol Res       Date:  2009-09-26       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.